National Health Investors/$NHI
1D1W1MYTD1Y5YMAX
Capital at risk
About National Health Investors
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
- Ticker
- $NHI
- Sector
- Real Estate
- Primary listing
- NYSE
- Employees
- 32
- Headquarters
- Murfreesboro, United States
- Website
- www.nhireit.com
NHI Metrics
BasicAdvanced
$3.3B
19.57
$3.46
0.56
$3.68
5.43%
Price and volume
Market cap
$3.3B
Beta
0.56
52-week high
$91.38
52-week low
$67.36
Average daily volume
363K
Dividend rate
$3.68
Financial strength
Current ratio
1.817
Quick ratio
1.195
Long term debt to equity
0.804
Total debt to equity
0.804
Dividend payout ratio (TTM)
105.26%
Interest coverage (TTM)
3.37%
Profitability
EBITDA (TTM)
289.674
Gross margin (TTM)
73.93%
Net profit margin (TTM)
38.28%
Operating margin (TTM)
45.57%
Effective tax rate (TTM)
0.44%
Revenue per employee (TTM)
$13,620,000
Management effectiveness
Return on assets (TTM)
4.39%
Return on equity (TTM)
10.72%
Valuation
Price to earnings (TTM)
19.57
Price to revenue (TTM)
7.462
Price to book
2.12
Price to tangible book (TTM)
2.12
Price to free cash flow (TTM)
13.076
Free cash flow yield (TTM)
7.65%
Free cash flow per share (TTM)
5.185
Dividend yield (TTM)
5.43%
Forward dividend yield
5.43%
Growth
Revenue change (TTM)
24.99%
Earnings per share change (TTM)
10.42%
3-year revenue growth (CAGR)
12.36%
10-year revenue growth (CAGR)
6.35%
3-year earnings per share growth (CAGR)
11.05%
10-year earnings per share growth (CAGR)
-2.22%
3-year dividend per share growth (CAGR)
0.74%
10-year dividend per share growth (CAGR)
0.50%
What the Analysts think about NHI
Analyst ratings (Buy, Hold, Sell) for National Health Investors stock.
Analyst projections of the future price of National Health Investors stock.
Bulls say / Bears say
Completed the USD 560 million sale of 35 NHC-leased properties, reducing leverage and boosting liquidity for private-pay senior housing investments (Reuters)
Signed letters of intent totaling USD 127.3 million at an average initial NOI yield of ~6.8%, with an active USD 420 million pipeline for SHOP and sale-leaseback investments, underscoring robust deal flow (PR Newswire)
Maintained a consolidated net debt to adjusted EBITDA ratio of 4.1x within its 3.5–4.5x target range and held investment-grade ratings from Moody’s, S&P Global, and Fitch, affirming financial discipline and capacity for growth (PR Newswire)
Shares have fallen 14% over the past six months to $71.74, reflecting investor skepticism despite a Q2 earnings beat (Investing.com)
Same-store SHOP NOI declined 6.2% year-over-year in Q2, indicating operational challenges in stabilized properties (Investing.com)
General & administrative expenses surged 44% YoY in Q2 to support SHOP platform build-out and CFO transition costs, pressuring normalized earnings (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2026.
NHI Financial Performance
Revenues and expenses
NHI Earnings Performance
Company profitability
Upcoming events
NHI News
AllArticlesVideos
Funds containing NHI
AllUSDGBPEUR
Fund name | Fund size | $NHI weighting |
|---|---|---|
iShares Developed Markets Property Yield$IDWP | $1.2B | 0.19% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.19% |
iShares Developed Markets Property Yield£IWDP | £859M | 0.19% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.19% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.11% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.